title: Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors.
authors.affiliation: Department of Development and Regeneration, Laboratory of Tissue Homeostasis and Disease, University of Leuven; and Department of Rheumatology, University Hospitals Leuven, Belgium. ellen.delanghe@uzleuven.be.
authors.forename: Ellen
authors.initials: E
authors.lastname: De Langhe
authors.affiliation: Department of Rheumatology, University Hospitals Leuven, Belgium.
authors.forename: Jan
authors.initials: J
authors.lastname: Lenaerts
authors.affiliation: Department of Radiology, University Hospitals Leuven, Belgium.
authors.forename: Philippe
authors.initials: P
authors.lastname: Demaerel
authors.affiliation: Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), Leuven; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven; and Department of Neurology, Leuven, Belgium.
authors.forename: Robin
authors.initials: R
authors.lastname: Lemmens
mesh_terms: D005260:Female; D006801:Humans; D009072:Moyamoya Disease / Q000188:drug therapy*; D000069283:Rituximab / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D000069283:Rituximab